DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Teradata Corp
TDC
Halozyme Therapeutics
HALO
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
US Stock MarketDetailed Quotes
DH Definitive Healthcare
- 4.135
- -0.205-4.72%
Trading Dec 19 13:46 ET
477.69MMarket Cap-1.34P/E (TTM)
4.390High4.050Low1.19MVolume4.390Open4.340Pre Close4.92MTurnover2.68%Turnover RatioLossP/E (Static)115.52MShares10.62052wk High0.94P/B183.56MFloat Cap3.19052wk Low--Dividend TTM44.39MShs Float50.300Historical High--Div YieldTTM7.83%Amplitude3.190Historical Low4.140Avg Price1Lot Size
Definitive Healthcare Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 104.83%19.43M | 16.64%14.04M | 10.91%16.59M | 15.77%41.19M | 211.59%4.71M | -11.21%9.49M | -22.25%12.04M | 9.71%14.96M | 41.12%35.58M | -200.02%-4.22M |
| Net income from continuing operations | 24.47%-187.82M | -2,538.41%-306.19M | 20.37%-12.72M | -1,097.85%-289.63M | -326.97%-13.36M | -3,512.03%-248.69M | -14.43%-11.61M | -22.49%-15.97M | 61.20%-24.18M | 137.19%5.89M |
| Depreciation and amortization | 0.28%13.06M | 0.08%12.79M | -2.01%12.68M | -9.06%51.75M | 2.48%13M | -1.25%13.03M | -18.99%12.78M | -15.13%12.94M | -5.08%56.9M | -16.74%12.69M |
| Deferred tax | 19.20%-37.96M | -12,511.68%-63.69M | -212.05%-3.11M | -53.26%-42.18M | 113.84%2.52M | -787.23%-46.98M | 86.44%-505K | 1,085.46%2.78M | -4,588.76%-27.52M | -3,004.09%-18.22M |
| Other non cash items | -83.18%609K | 19.67%4M | 36.30%4.14M | 19.77%14.12M | 3.86%4.12M | 47.25%3.62M | 0.94%3.35M | 48.03%3.04M | 14.98%11.79M | 67.45%3.97M |
| Change In working capital | 70.02%-3.33M | -36.52%-6.72M | -122.48%-194K | -58.48%-30.39M | 25.80%-15.23M | -313.83%-11.1M | -491.41%-4.92M | -68.84%863K | -663.56%-19.17M | -552.64%-20.52M |
| -Change in receivables | 44.88%7.95M | 76.37%12.2M | -56.95%3M | 106.13%811K | 27.72%-18.56M | 294.82%5.49M | 2.58%6.92M | -18.30%6.97M | -23.27%-13.22M | -61.43%-25.68M |
| -Change in prepaid assets | -31.74%-2.95M | -1,370.67%-2.86M | 63.15%-1.4M | -5,534.65%-7.16M | 49.72%-1.35M | -281.13%-2.24M | -64.11%225K | -648.55%-3.8M | 96.59%-127K | 15.37%-2.68M |
| -Change in payables and accrued expense | 256.76%5.12M | -347.36%-2.06M | -113.51%-8.23M | -57.62%1.33M | 208.35%2.92M | -78.99%1.43M | -58.50%832K | -28.59%-3.86M | -8.35%3.14M | -136.46%-2.69M |
| -Change in other current liabilities | --0 | --0 | ---602K | --0 | --0 | --0 | --0 | --0 | ---6.4M | --0 |
| -Change in other working capital | 14.81%-13.44M | -8.58%-14.01M | 354.72%7.04M | -890.24%-25.37M | -83.26%1.76M | -99.12%-15.78M | -58.89%-12.9M | -47.53%1.55M | -130.07%-2.56M | 23.33%10.53M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 104.83%19.43M | 16.64%14.04M | 10.91%16.59M | 15.77%41.19M | 211.59%4.71M | -11.21%9.49M | -22.25%12.04M | 9.71%14.96M | 41.12%35.58M | -200.02%-4.22M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 116.58%8.96M | 1,014.48%14.93M | 28.19%-24.03M | 87.23%-31.78M | 180.14%54.41M | -1,256.90%-54.06M | 113.16%1.34M | 79.94%-33.47M | -432.63%-248.9M | -65.30%-67.89M |
| Net PPE purchase and sale | -151.48%-767K | 44.59%-410K | 80.12%-266K | 64.24%-2.98M | 87.81%-594K | 83.76%-305K | 5.49%-740K | -68.51%-1.34M | -23.70%-8.33M | -355.66%-4.87M |
| Net business purchase and sale | --0 | --0 | ---13.53M | 20.02%-45.02M | --0 | -22,278.82%-45.02M | --0 | --0 | -40.74%-56.3M | --0 |
| Net investment purchase and sale | 211.42%9.73M | 637.69%15.34M | 68.14%-10.24M | 108.80%16.22M | 187.28%55M | -278.13%-8.73M | 122.13%2.08M | 70.67%-32.13M | ---184.28M | ---63.02M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 116.58%8.96M | 1,014.48%14.93M | 28.19%-24.03M | 87.23%-31.78M | 180.14%54.41M | -1,256.90%-54.06M | 113.16%1.34M | 79.94%-33.47M | -432.63%-248.9M | -65.30%-67.89M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -16.39%-12.07M | -150.79%-14.12M | -387.77%-17.19M | 4.17%-25.58M | 35.90%-6.06M | -69.52%-10.37M | 16.55%-5.63M | 19.45%-3.53M | -106.95%-26.7M | -104.03%-9.46M |
| Net issuance payments of debt | -100.12%-3.44M | -99.94%-3.44M | -100.00%-3.44M | -25.00%-8.59M | -100.00%-3.44M | 0.00%-1.72M | 0.00%-1.72M | 0.00%-1.72M | 96.55%-6.88M | -0.06%-1.72M |
| Net common stock issuance | ---8.03M | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 | ---- |
| Cash dividends paid | 98.75%-98K | ---- | ---- | 4.58%-12.28M | 73.21%-1.59M | -376.15%-7.87M | ---- | ---- | -58.35%-12.87M | -499.80%-5.93M |
| Net other financing activities | 36.70%-495K | 10.69%-969K | -661.68%-13.76M | 32.26%-4.71M | 42.69%-1.04M | 71.51%-782K | -520.54%-1.09M | 32.03%-1.81M | 38.06%-6.95M | 68.84%-1.81M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -16.39%-12.07M | -150.79%-14.12M | -387.77%-17.19M | 4.17%-25.58M | 35.90%-6.06M | -69.52%-10.37M | 16.55%-5.63M | 19.45%-3.53M | -106.95%-26.7M | -104.03%-9.46M |
| Net cash flow | ||||||||||
| Beginning cash position | -8.67%120.9M | -15.18%105.99M | -10.86%130.98M | -62.08%146.93M | -66.15%77.46M | -41.99%132.39M | -45.62%124.96M | -62.08%146.93M | 1,464.13%387.5M | 20.59%228.83M |
| Current changes in cash | 129.72%16.33M | 91.74%14.85M | -11.80%-24.64M | 93.26%-16.18M | 165.05%53.05M | -9,475.09%-54.94M | 634.94%7.75M | 86.02%-22.04M | -166.15%-240.02M | -141.23%-81.56M |
| Effect of exchange rate changes | 2,823.08%380K | 117.08%55K | -627.69%-343K | 140.07%218K | 239.58%462K | -67.50%13K | -122.07%-322K | 160.19%65K | -321.71%-544K | -308.64%-331K |
| End cash Position | 77.65%137.61M | -8.67%120.9M | -15.18%105.99M | -10.86%130.98M | -10.86%130.98M | -66.15%77.46M | -41.99%132.39M | -45.62%124.96M | -62.08%146.93M | -62.08%146.93M |
| Free cash flow | 103.28%18.67M | 20.65%13.63M | 19.85%16.32M | 40.22%38.21M | 145.26%4.12M | 4.26%9.18M | -23.14%11.3M | 6.08%13.62M | 47.46%27.25M | -388.60%-9.09M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |